From mundane to classic: Sinomenine as a multi‐therapeutic agent
British Journal of Pharmacology · 2025-05 · 182 (10) · 2159-2180
DOI: 10.1111/bph.16267 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, online erschienen am 27.11.2023. Verfasst von Dan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Chi…. Hauptthemen laut MEDLINE: Morphinans. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 181 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Start-Up Research Funding from Zhejiang Ocean University, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Sinomenine is an active substance extracted from the traditional Chinese medicine Sinomenium acutum. Sinomenine has been shown to mediate a wide range of pharmacological actions and is known to possess good anti‐inflammatory, immunosuppressive, antitumor, neuroprotective, antiarrhythmic and other pharmacological effects. Understanding the underlying mechanisms and the association between the targets and the pharmaceutical effects on different diseases is crucial to the discovery and design of new treatment strategies. In this review, we aim to give a systematic and comprehensive overview of the research progress of sinomenine over the past 20 years. We first describe the metabolism of sinomenine in vivo and then summarize the pharmacological actions of sinomenine on different diseases. Furthermore, the potential binding properties of sinomenine and the potential of developing new sinomenine‐based drugs are also reviewed. LINKED ARTICLES This article is part of a themed issue Natural Products and Cancer: From Drug Discovery to Prevention and Therapy. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.10/issuetoc
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Macao Centre for Research and Development in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
- The International Eye Research Institute of The Chinese University of Hong Kong (Shenzhen), Shenzhen, China.
- Center for Biological Science and Technology, Advanced Institute of Natural Sciences, Beijing Normal University at Zhuhai, Zhuhai, China.
- National Engineering Research Center For Marine Aquaculture, Institute of Innovation & Application, Zhejiang Ocean University, Zhoushan, China.
Förderung
- National Natural Science Foundation of China
- Start-Up Research Funding from Zhejiang Ocean University
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- Sichuan Province Science and Technology Support Program
- Macao Science and Technology Development Fund (FDCT)
- Natural Science Foundation of Guangdong Province, China
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
- National Natural Science Foundation of China-Guangdong Joint Fund
Zitieren
APA
Li, D., Zhong, Z., Ko, C. N., Tian, T., & Yang, C. (2025). From mundane to classic: Sinomenine as a multi‐therapeutic agent. British Journal of Pharmacology, 182(10), 2159-2180. https://doi.org/10.1111/bph.16267
Vancouver
Li D, Zhong Z, Ko CN, Tian T, Yang C. From mundane to classic: Sinomenine as a multi‐therapeutic agent. British Journal of Pharmacology. 2025;182(10):2159-2180. doi:10.1111/bph.16267
BibTeX
@article{Li2025,
author = {Li, Dan and Zhong, Zhangfeng and Ko, Chung-Nga and Tian, Tiantian and Yang, Chao},
title = {From mundane to classic: Sinomenine as a multi‐therapeutic agent},
journal = {British Journal of Pharmacology},
year = {2025},
volume = {182},
number = {10},
pages = {2159--2180},
doi = {10.1111/bph.16267}
}
EUVIMED